MedPath

Does the Cerebroplacental Ratio (CPR) Predict Adverse Outcomes in Low Risk Pregnancies?

Terminated
Conditions
Cerebroplacental Ratio
Registration Number
NCT03066726
Lead Sponsor
Rutgers, The State University of New Jersey
Brief Summary

Ultrasound Doppler studies are used during pregnancy to help manage pregnancies complicated by fetal growth restriction. The cerebroplacental ratio may predict adverse outcomes in low risk pregnancies. In a prospective study, the investigators will examine whether fetuses with an abnormal CPR at or near term are at increased risk for being delivered by cesarean,

Detailed Description

This is a multicenter prospective study of low-risk nulliparous women who will be recruited if they are having an ultrasound at 36 weeks of estimated gestational age or greater. As part of the study, women will have umbilical and middle cerebral artery Doppler studies and the CPR will be calculated by dividing the middle cerebral artery PI by the umbilical artery PI. Providers caring for study subjects will be blinded to this result. Pregnancy outcomes in women with CPR values less than the 10th percentile for gestational age will be compared to those with CPR values above the 10th percentile.

A secondary aim of the study is to analyze CPR as a continuous variable.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
580
Inclusion Criteria
  • Nulliparous pregnant women between the ages of 18 and 45 years with low risk pregnancies who present for obstetrical ultrasound at 36 weeks of gestation or later with a planned delivery at a Perinatal Research Consortium hospital.
Exclusion Criteria
  • Multifetal pregnancy at the time of presentation
  • Known fetal chromosomal anomaly
  • Known fetal malformation
  • Preeclampsia
  • Fetal growth restriction
  • Multiparity
  • Prior cesarean section
  • Placental abnormalities such as previa or accreta
  • Pregestational diabetes
  • Plan to deliver outside the Perinatal Research Consortium affiliated hospitals

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cesarean deliveryFrom labor to delivery

Cesarean delivery rate for non reassuring fetal heart tracings

Secondary Outcome Measures
NameTimeMethod
Cases of small for gestational age undetected prenatallyAt time of delivery

Neonates that were small for gestational age at time of delivery but were not detected prenatally

Cord blood gasesAt the time of delivery

If obtained by the provider, umbilical (arterial or venous) cord pH

Incidence of category 2 or 3 tracingsDuring labor

As defined by the National Institutes of Health-National Institute of Child Health and Human Development Fetal Heart Tracings definitions and classifications

Rate of operative vaginal deliveryAt time of delivery

Vaginal deliveries needing forceps or vacuum assistance

Total cesarean section rateFrom labor to delivery

Cesarean delivery rate for other indications other than non reassuring fetal heart tracings

Birthweight/ birthweight percentileAt time of delivery

Neonate birth weight and percentiles according to established weight charts will be recorded

Distribution of CPR by estimated fetal weightMeasured during ultrasound between 36 weeks gestational age and delivery of the pregnancy.

We will assess whether there is an association between the CPR and sonographic estimation of fetal weight.

Neonatal Intensive Care Unit admissionUp to 28 days from delivery of the pregnancy

Percentage of neonates admitted to the neonatal intensive care unit

Apgar scores at 1 and 5 minuteScores assigned at 1 and 5 minutes of life by clinical staff.

Standard assessment tool applied to all neonates in participating centers by clinical staff

Composite neonatal outcomeUp to 28 days from delivery of the pregnancy.

The investigators will record a composite neonatal outcome including-respiratory distress, apnea, infection, hypoglycemia, hyperbilirubinemia, hypothermia, neurologic complication and neonatal death.

Trial Locations

Locations (6)

New York Presbyterian-Queens Hospital

🇺🇸

Flushing, New York, United States

Columbia University

🇺🇸

New York, New York, United States

Rutgers, The State University of New Jersey

🇺🇸

New Brunswick, New Jersey, United States

Virtua Medical Group

🇺🇸

Sewell, New Jersey, United States

Saint Peters University Hospital

🇺🇸

New Brunswick, New Jersey, United States

Winthrop University Hospital

🇺🇸

Mineola, New York, United States

© Copyright 2025. All Rights Reserved by MedPath